| Clinical Study on the Safety, Efficacy and Pharmacokinetics of Universal CLL1 Chimeric Antigen Receptor T-Cell in Relapsed/Refractory Acute Myeloid Leukemia (NCT07432100) | Mingfeng Zhao | 2026-02-01 |
| Drug-Drug Interaction Between DW4421 and Amoxicillin/Clarithromycin (NCT07382661) | Daewon Pharmaceutical Co., Ltd. | 2026-02-01 |
| Early Inflammatory-Immune Stratification and Precision Glucocorticoid Intervention in Acute Respiratory Failure Induced by Community-Acquired Pneumonia (NCT07357935) | Qingyuan Zhan | 2026-02-01 |
| Nebulized Human Amniotic Fluid in Patients With Interstitial Lung Disease (NCT07372989) | Maule Stem Cell Research Institute, Inc. | 2026-02-01 |
| A Phase 1 Study of ABF-101 in Single- and Multiple-Ascending Doses (NCT07330674) | Aptabio Therapeutics, Inc. | 2026-02-01 |
| SAD Study in Patients With Parkinson's Disease and Motor Fluctuations (NCT07422675) | Serina Therapeutics | 2026-02-01 |
| Establishing a Controlled Human Infection Model for Influenza H3N2 as a Foundation for Pandemic Preparedness (NCT07305207) | Dalhousie University | 2026-02-01 |
| N-803 Maintenance Therapy Post CAR T-cell Therapy in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphomas (NCT07049432) | University of Utah | 2026-02-01 |
| A Study Testing the Effects of Different THC Doses on Psychological and Biological Function (NCT07346690) | University of Calgary | 2026-02-01 |
| A Trial to Test Intermittent Deep Brain Stimulation of Nucleus Basalis of Meynert to Treat Alzheimers. (NCT07218081) | Augusta University | 2026-02-01 |
| Efficacy and Safety of CRC01 in Participants With Severe, Refractory Systemic Lupus Erythematosus (NCT07364396) | Curocell Inc. | 2026-02-01 |
| FMT in Triple Negative Breast Cancer Guided by ctDNA (NCT07292142) | Jewish General Hospital | 2026-02-01 |
| Sodium Bicarbonate as an Alternative to Potassium Citrate for Kidney Stones (NCT07408076) | University of California, Los Angeles | 2026-02-01 |
| Kamlanoflast In Amyotrophic Lateral Sclerosis (NCT07396818) | Inflammasome Therapeutics | 2026-02-01 |
| AAV2-hAADC for Parkinson's Disease (PDCS-01) (NCT07267065) | Krzysztof Bankiewicz | 2026-02-01 |
| Dual-Target CAR-NK Cells for Biomarker-Selected Advanced Colorectal Cancer (NCT07462650) | Beijing Biotech | 2026-02-01 |
| Study to Evaluate Safety and Dosimetry of [18F]GEH121224 in Patients With Locally Advanced or Metastatic Breast Cancer (NCT05634954) | GE Healthcare | 2026-02-01 |
| Study of CD19 CAR-T Therapy for Refractory SLE (NCT07403097) | Chongqing Precision Biotech Co., Ltd | 2026-02-01 |
| Beta-sitosterol for Subarachnoid Hemorrhage: Mechanistic Analysis of Recovery and Therapy (NCT07457333) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2026-02-01 |
| Feasibility and Tolerability of IMLYGIC for the Treatment of Cutaneous Neurofibromas in Adults With NF1 (NCT07102394) | Johns Hopkins University | 2026-02-01 |
| Study of MCLA-129 in Combination With Ensartinib in Patients With Advanced Solid Tumors. (NCT07448116) | Betta Pharmaceuticals Co., Ltd. | 2026-01-31 |
| Safety and Tolerability Study of Mesenchymal Stem Cells, HeXell-2020, in Elderly Subjects With Mild to Moderate Frailty Syndrome (NCT07144072) | Hexun Biosciences Co., LTD. | 2026-01-31 |
| Safety and Efficacy of Human Adipose-Derived Stem Cell Exosomes in Acute Ischemic Stroke (NCT07398612) | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 2026-01-31 |
| Clinical Study of Anti-CLL1-CD33-NKG2D Bicephali CAR-T for Relapsed/Refractory Acute Myeloid Leukemia (NCT07370064) | Xuzhou Medical University | 2026-01-31 |
| Evaluate the Pharmacokinetics, Safety, and Tolerability of NSHO-101 in Healthy Participants (NCT07403552) | Ensho Therapeutics, Inc. | 2026-01-31 |
| Zorifertinib With Osimertinib for NSCLC With Meningeal Progression (NCT07361705) | Alpha Biopharma (Jiangsu) Co., Ltd. | 2026-01-31 |
| A Study of Remternetug (LY3372993) in Healthy Chinese Participants (NCT07346495) | Eli Lilly and Company | 2026-01-31 |
| An Open-label, Single-arm, Prospective, Multicenter, Phase I/II Clinical Study on the Safety and Efficacy of CD19/BCMA CAR-T Cell Therapy for Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia (NCT07324889) | Yihao Wang | 2026-01-31 |
| A Phase Ib/II Study to Evaluate HLX43 Combined With HLX07 or Serplulimab in Patients With Advanced or Metastatic Colorectal Cancer (NCT07358585) | Shanghai Henlius Biotech | 2026-01-31 |
| Dose-Finding Study of NBX-100 in Healthy Adult Participants (NCT07399899) | Neurala Biosciences | 2026-01-31 |
| A Phase I/II Study to Evaluate XNW34017 in Patients With Advanced or Metastatic Solid Tumor (NCT07327294) | Evopoint Biosciences Inc. | 2026-01-31 |
| Adebrelimab Combined With Gemcitabine, Cisplatin, and Simvastatin for Advanced Biliary Tract Cancer (NCT07392541) | Tongji Hospital | 2026-01-30 |
| Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers (NCT07227298) | Pfizer | 2026-01-30 |
| Study to Evaluating PRO-240 Ophthalmic Solution Compared to Optive® (NCT06375343) | Laboratorios Sophia S.A de C.V. | 2026-01-30 |
| DC/MM Fusion Vaccine With BCMA CAR-T in R/R MM (NCT07377435) | David Avigan | 2026-01-30 |
| Single-Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Pevifoscorvir Sodium (ALG-000184) in Subjects With Moderate Hepatic Impairment and in Healthy Subjects With Normal Hepatic Function (NCT07342868) | Aligos Therapeutics | 2026-01-30 |
| Evaluation of Lumitrace for Visualizing Ureters During Abdominopelvic Surgeries (NCT07080008) | MediBeacon | 2026-01-30 |
| Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors (NCT07397338) | Revolution Medicines, Inc. | 2026-01-30 |
| A Study of GC203 TIL in Advanced Solid Tumors (NF) (NCT07256756) | Shanghai Juncell Therapeutics | 2026-01-30 |
| A Phase 1b/2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Combination With Low Intensity Chemotherapy in Older Patients With Newly Diagnosed B-Cell Acute Lymphoblastic Leukemia (NCT07153796) | M.D. Anderson Cancer Center | 2026-01-30 |
| A Clinical Trial Evaluating the Safety of TD001 In Patients With PSMA-Expressing Metastatic Prostate Cancer (NCT07258407) | T.O.A.D. Oncology SA | 2026-01-30 |
| A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL628 in Participants With Early Alzheimer's Disease (NCT07328451) | Denali Therapeutics Inc. | 2026-01-30 |
| Exploratory Study of LP-98 for Injection in ART-Naive HIV-Infected Individuals (NCT07433387) | Shanxi Kangbao Biological Product Co., Ltd. | 2026-01-29 |
| Study of the Safety, Tolerability, Pharmacokinetics of VV913 Capsules in Chinese Healthy Participants (NCT07372703) | Vigonvita Life Sciences | 2026-01-29 |
| A Phase 1/2 Study of GW5282 in Participants With Advanced Solid Tumors (NCT07328217) | Dizal Pharmaceuticals | 2026-01-29 |
| Low-Tech Treatments for Obstructive Sleep Apnea (NCT07301710) | Uniformed Services University of the Health Sciences | 2026-01-29 |
| The Use of Isocapnic Hyperventilation (iHV) for Treatment of Methanol Poisoned Patients (NCT06173817) | Oslo University Hospital | 2026-01-29 |
| A Study of MR001 in Patients With Locally Recurrent or Metastatic Advanced Triple-Negative Breast Cancer (TNBC) (NCT07208149) | Shenzhen Majory Biotechnology Co., Ltd. | 2026-01-29 |
| HS-20093 in Patients With Advanced Gastric and Gastroesophageal Junction Adenocarcinoma (NCT07462923) | Hansoh BioMedical R&D Company | 2026-01-29 |
| A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003) (NCT07227597) | Merck Sharp & Dohme LLC | 2026-01-29 |
| A Study of LUCAR-G79D in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus (r/r SLE) and Idiopathic Inflammatory Myopathies (r/r IIM) (NCT07331272) | Nanjing Legend Biotech Co. | 2026-01-29 |
| Platform Study of VSV-Based Recombinant Oncolytic Viruses for the Treatment of Advanced Malignant Tumors (NCT07656116) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2026-01-29 |
| A Study to Investigate the Improvement of Photosensitivity in Terms of Skin Lesions Associated With CEP Following Administration of Oral ATL-001 (Ciclopirox Oral Solution) in Participants Aged >18 Years of Age With CEP (NCT07024316) | Atlas Molecular Pharma | 2026-01-29 |
| Study Evaluating Safety & Tolerability of Migaldendranib in Healthy Volunteers (NCT07370155) | Ashvattha Therapeutics, Inc. | 2026-01-29 |
| This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma (NCT07121946) | LTZ Therapeutics, Inc. | 2026-01-29 |
| Phase 1/2 Open-Label Dose-Escalation Study to Evaluate Safety of a Single Intravitreal Injection of RTx-021 in Patients With Stargardt Disease (NCT07439887) | Ray Therapeutics, Inc. | 2026-01-28 |
| A Phase 1 Study to Evaluate the Safety and Immunogenicity of GC4006A in Healthy Adults (NCT07728396) | GC Biopharma Corp | 2026-01-28 |
| Evaluation of RAS Inhibitor Treatment in Participants With Advanced or Metastatic Solid Tumors Harboring RAS Mutations (NCT07252479) | Adlai Nortye Biopharma Co., Ltd. | 2026-01-28 |
| A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function (NCT07315360) | Pfizer | 2026-01-28 |
| A Phase I/II, Dose-finding Study to Assess the Safety, Reactogenicity, and Immunogenicity of a Broadly Protective Sarbecovirus Vaccine (GBP511) in Healthy Adults. (NCT07280858) | SK Bioscience Co., Ltd. | 2026-01-28 |
| A Prospective, Multicenter, Phase Ib/II Trial of Ivonescimab (AK112) Combined With Albumin-Paclitaxel and Cisplatin as Neoadjuvant Therapy for ESCC (NCT07385001) | Tang-Du Hospital | 2026-01-28 |
| A Study Investigating the Safety, Absorption, Elimination, and the Effect on the Immune System of ACI-19764 in Healthy Participants (NCT07463196) | AC Immune SA | 2026-01-28 |
| Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE) (NCT07172958) | Children's National Research Institute | 2026-01-27 |
| Evaluate the Pharmacokinetic Interaction and the Safety of AD-2321 and AD-2322 (NCT07312799) | Addpharma Inc. | 2026-01-27 |
| A Study of PATAS Trifluoroacetate Using Single Ascending Doses in Healthy Volunteers (NCT07223333) | AdipoPharma LLC | 2026-01-27 |
| A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Given With or Without Other Anticancer Drugs (NCT07336446) | AstraZeneca | 2026-01-27 |
| Compare and Evaluate the Safety and PK Data of a Single Dose Administration of 'AD-115A' or 'AD-1151' (NCT07385235) | Addpharma Inc. | 2026-01-27 |
| A Trial of LBL-024 Monotherapy or Combination Drug in Patients With Triple Negative Breast Cancer (NCT07281976) | Nanjing Leads Biolabs Co.,Ltd | 2026-01-27 |
| Intestinal Microbiome Transplant in ALS (NCT07017946) | Duke University | 2026-01-27 |
| A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7812653 in Participants With Early Symptomatic Alzheimer's Disease (eAD) (NCT07234942) | Hoffmann-La Roche | 2026-01-27 |
| Testing RG1-VLP Vaccine to Prevent HPV-related Cancers (NCT05985681) | National Cancer Institute (NCI) | 2026-01-27 |
| Drug-drug Interaction Study With AZD5335 and Itraconazole in Participants With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer (NCT07402915) | AstraZeneca | 2026-01-26 |
| Food-Effect, Single and Multiple Dose Pharmacokinetics, Safety and Tolerability Study of 4-MUST, 128 mg, Tablets in Healthy Volunteers (NCT07594977) | Valenta Pharm JSC | 2026-01-26 |
| A Study to Evaluate EDG-7500 in Adults With Hepatic Impairment (NCT07324616) | Edgewise Therapeutics, Inc. | 2026-01-26 |
| A Study to Assess the Safety of ARGX-124 in Healthy Volunteers (NCT07377396) | argenx | 2026-01-26 |
| A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma (NCT07219212) | Johnson & Johnson Enterprise Innovation Inc. | 2026-01-26 |
| Dose-Escalation and Dose-Expansion Study of BSI-082 Monotherapy and Combined Therapy in Patients With Advanced or Metastatic Solid Tumors (NCT07086768) | Lei Zheng | 2026-01-26 |
| Evaluate the Safety, Tolerability, PK, and PD of JMT206 Injection in Healthy Participants (NCT07419698) | Shanghai JMT-Bio Inc. | 2026-01-26 |
| Study of Ultra-Fast BCMA/CD70 CAR-T Therapy for Refractory SLE (NCT07318259) | Chongqing Precision Biotech Co., Ltd | 2026-01-26 |
| A Study of Single Dose of BL0175 in Postmenopausal Women (NCT07366632) | Shanghai Best-Link Bioscience, LLC | 2026-01-26 |
| Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors (NCT07287917) | Aminex Therapeutics, Inc. | 2026-01-26 |
| A Study to Compare the Auto-injector and Pre-filled Syringe of CT-P52 in Healthy Male Subjects (NCT07367958) | Celltrion | 2026-01-26 |
| Study to Compare and Evaluate the Safety and Pharmacokinetics After Subcutaneous Injection of HUC2-676 or HUC2-676-R in Healthy Adult Subjects (NCT07337174) | Huons Co., Ltd. | 2026-01-25 |
| Exploratory Clinical Study of FAP mRNA Vaccine in Patients With Advanced Malignant Solid Tumors (NCT07363369) | West China Hospital | 2026-01-25 |
| A First-in-Human Single and Multiple Ascending Dose Study of MT-251 (NCT07423299) | Mirador Therapeutics, Inc. | 2026-01-23 |
| A Study to Evaluate the Pharmacokinetic Interaction and the Safety of AD-231A and AD-231B and AD-231C (NCT07312773) | Addpharma Inc. | 2026-01-23 |
| Drug-Drug Interaction Study of ABP-671 in Gout Patients (NCT07367971) | Atom Therapeutics Co., Ltd | 2026-01-23 |
| A Food Effect Study of QLS1410 in Healthy Chinese Adults (NCT07358858) | Qilu Pharmaceutical Co., Ltd. | 2026-01-23 |
| Pilot Study of RR-HNK in OCD (NCT06575075) | Carolyn Rodriguez | 2026-01-23 |
| Decitabine in Combination With Standard of Care Therapy for the Treatment of Surgically Resectable HPV-Negative Head and Neck Cancer (NCT06997094) | Mayo Clinic | 2026-01-23 |
| A Clinical Trial to Evaluate the Effect of Ulonivirine (MK-8507) on Heart Rhythm in Healthy Adults (MK-8507-012) (NCT07305831) | Merck Sharp & Dohme LLC | 2026-01-22 |
| Tegavivint With Gemcitabine in Patients With Relapsed or Refractory Osteosarcoma (NCT07144254) | Emory University | 2026-01-22 |
| A Study in Healthy Men to Test How BI 1584862 is Processed in the Body (NCT07336758) | Boehringer Ingelheim | 2026-01-22 |
| A Phase I Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TQB3122 Capsules in Subjects With Advanced Malignant Tumors (NCT07269145) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2026-01-22 |
| A Clinical Study of TI-0032-III Injection in Patients With Relapsed and Refractory Autoimmune Diseases (NCT07413341) | Therorna | 2026-01-22 |
| Safety, Tolerability, and Pharmacokinetics of Multiple-Dose RFUS-949 in Healthy Chinese Participants (NCT07676357) | The Affiliated Hospital of Qingdao University | 2026-01-22 |
| A Clinical Trial to Evaluate the Safety and the Pharmacokinetics of AD-116 Compared to AD-1161 in Healthy Adult Male Volunteers (NCT07103278) | Addpharma Inc. | 2026-01-22 |
| Study to Assess the Safety and Pharmacokinetics of AVD275 Injection in Patients With Osteoarthritis of the Knee (NCT07338266) | Avidence Therapeutics | 2026-01-22 |
| Preoperative Nebulized Dexmedetomidine Versus Nebulized Magnesium Sulphate in Reducing Emergence Agitation in FESS (NCT07677917) | Ain Shams University | 2026-01-22 |
| A Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CITY-FXI in Healthy Adults and Adults With FV Leiden or Prothrombin G20210A Mutation (NCT07430397) | City Therapeutics | 2026-01-22 |